Big Lots falls following Q3 earnings report Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- BioCryst (BCRX) up 8% after announcing the FDA has approved oral, once-daily Orladeyo for prophylaxis to prevent attacks of hereditary angioedema in adults and pediatric patients 12 years and older
- Dynavax (DVAX) up 5% after Clover Biopharmaceuticals announced clinical data from its Phase 1 trial demonstrating that its protein-based COVID-19 S-Trimer vaccine candidates in combination with adjuvants from either GlaxoSmithKline (GSK) or the company induces strong immune responses, including neutralizing antibodies and cell-mediated immunity, as well as favorable safety and tolerability profiles in 150 adult and elderly participants
- Cinemark (CNK) up 6% after B. Riley Securities analyst Eric Wold said he thinks yesterday's reaction in exhibition names to Warner Bros. (T) saying its entire 2021 film slate will have simultaneous day-and-date releases in both theaters and on HBO Max is likely to prove to be an overreaction
UP AFTER EARNINGS -
- PagerDuty (PD) up 17%
-
DocuSign (DOCU) up 6%
- Cloudera (CLDR) up 11%
DOWN AFTER EARNINGS -
- Big Lots (BIG) down 3%
- Ollie's Bargain Outlet (OLLI) down 12%
- Ulta Beauty (ULTA) down 2%
- Marvell (MRVL) down 3%
LOWER -
- Li Auto (LI) down 5% after its 47M share secondary offering priced at $29.00 per American depositary share, or ADS
- Precision BioSciences (DTIL) down 2% after announcing one NHL patient who was treated with PBCAR0191 and eLD died at day 42 with grade 5 sepsis
Symbols:
BCRX DVAX DTIL CNK PD DOCU - $231.09 /
+13.52 (+6.21%)
CLDR BIG OLLI ULTA MRVL LI Keywords: Fly Intel, Wall Street, Top Stories, Stocks